RecruitingNCT00001595
Rare condition
Prolactinoma
5
studies recruiting now
as of 7 Sept 2026
31
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
11 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT07463235
Safety and Potency of a High Cabergoline Dosage in Microprolactinomas
RecruitingPhase 2NCT06295952
A Study of Pasireotide in People With Prolactinoma
RecruitingNCT07268183
How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors
RecruitingPhase 4NCT07045935
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Prolactinoma studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Prolactinoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Prolactinoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (CDH23, MEN1, AIP).
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).